AU2001234616A1 - Vaccine composition, process and methods - Google Patents

Vaccine composition, process and methods

Info

Publication number
AU2001234616A1
AU2001234616A1 AU2001234616A AU3461601A AU2001234616A1 AU 2001234616 A1 AU2001234616 A1 AU 2001234616A1 AU 2001234616 A AU2001234616 A AU 2001234616A AU 3461601 A AU3461601 A AU 3461601A AU 2001234616 A1 AU2001234616 A1 AU 2001234616A1
Authority
AU
Australia
Prior art keywords
methods
vaccine composition
vaccine
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001234616A
Inventor
Vic Jira
Vichai Jirathitical
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001234616A1 publication Critical patent/AU2001234616A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2001234616A 2000-01-31 2001-01-29 Vaccine composition, process and methods Abandoned AU2001234616A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US49460700A 2000-01-31 2000-01-31
US09494607 2000-01-31
US22752000P 2000-08-24 2000-08-24
US60227520 2000-08-24
PCT/US2001/002811 WO2001054717A1 (en) 2000-01-31 2001-01-29 Vaccine composition, process and methods

Publications (1)

Publication Number Publication Date
AU2001234616A1 true AU2001234616A1 (en) 2001-08-07

Family

ID=26921509

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001234616A Abandoned AU2001234616A1 (en) 2000-01-31 2001-01-29 Vaccine composition, process and methods

Country Status (2)

Country Link
AU (1) AU2001234616A1 (en)
WO (1) WO2001054717A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1279404A1 (en) 2001-07-26 2003-01-29 Istituto Superiore di Sanità Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases
US9701737B2 (en) * 2003-02-19 2017-07-11 Camas, Incorporated Immunogen adherence and method of making and using same
BRPI0614999A2 (en) 2005-08-11 2011-04-26 Harvard College method of producing a dry powder and said dry powder
NZ595748A (en) 2006-09-11 2013-07-26 Zoetis P Llc Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
RU2719586C9 (en) * 2014-06-13 2020-05-21 Алдар БУРИНБАЙАР Oral composition and methods of immunotherapy
CN107281481B (en) * 2017-08-02 2020-10-09 华派生物工程集团有限公司 Heat-resistant freeze-drying protective agent for pseudorabies live vaccine, preparation method of heat-resistant freeze-drying protective agent, freeze-dried vaccine and preparation method of freeze-dried vaccine
US11523988B2 (en) * 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695454A (en) * 1985-04-01 1987-09-22 New York Blood Center, Inc. Process for preparing hepatitis B surface antigen containing particles in novel forms which are highly immunogenic
US5262177A (en) * 1986-02-07 1993-11-16 Oncogen Recombinant viruses encoding the human melanoma-associated antigen
US5256767A (en) * 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5518725A (en) * 1989-09-25 1996-05-21 University Of Utah Research Foundation Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
US5639461A (en) * 1994-09-30 1997-06-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Influenza machine

Also Published As

Publication number Publication date
WO2001054717A1 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
AU2002217226A1 (en) Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate
AU3614901A (en) Polyorganosilsesquioxane and process for preparing the same
AU2002213273A1 (en) Stenoprophiluric matrices, and methods of making and using the same
AU2002234076A1 (en) Construction composition, structure, and method
AU2001289684A1 (en) Glass-ceramics, process for their preparation and use
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
AU2002243392A1 (en) Immunogenic proteoliposomes, and uses thereof
AU2001233932A1 (en) Method and composition
AU2000254308A1 (en) Pyrazolopyrimidinone derivatives, process for their preparation and their use
AU2001234616A1 (en) Vaccine composition, process and methods
AU2001295672A1 (en) Vaccine composition and stabilisation method
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
MXPA03002875A (en) Vaccine composition and stabilisation method.
HUP0100146A3 (en) 3-(1-hydroxy-pentylidene)-5-nitro-3h-benzofuran-2-one, process for its preparation and use thereof
AU2001261317A1 (en) Immunostimulant compositions and associated methods
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
AU2001267541A1 (en) Vaccine composition
AU2002239775A1 (en) Chemical-library composition and method
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
AU2001267769A1 (en) Process
AU2001211674A1 (en) Naphthomelanins, process for their preparation and compositions thereof
AU6730001A (en) Component, method for production and use thereof
AU2001249194A1 (en) Immunokine composition and method
AU2001294181A1 (en) Novel protein, process for producing the same and use thereof
AU4240401A (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof